Lance Nethercott
Foot & Ankle Surgery · Puyallup, WANPI 1891119129
Payments from drug & device makers
Across 85 payments — averaging $26.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$461
- Smith+Nephew$420
- Paragon 28, Inc.$264
- Biowound Solutions, Inc.$199
- Medtronic$181
- Averitas Pharma Inc.$130
- plus $637 from 15 others
What the payments were for
- Travel & lodging$1828%
- Food & beverage$2,11192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 30 | $461 |
| Smith+Nephew | 26 | $420 |
| Paragon 28, Inc. | 3 | $264 |
| Biowound Solutions, Inc. | 1 | $199 |
| Medtronic | 2 | $181 |
| Averitas Pharma Inc. | 1 | $130 |
| Summit Surgical Corp. | 1 | $96 |
| Polynovo North America LLC | 1 | $80 |
| Zimmer Biomet | 2 | $76 |
| Bioventus LLC | 1 | $56 |
| Next Science LLC | 5 | $52 |
| Osiris Therapeutics Inc. | 1 | $50 |
| Acell, Inc. | 2 | $42 |
| Invictus Surgical Incorporated | 2 | $40 |
| Globus Medical | 1 | $33 |
| Heron Therapeutics, Inc. | 1 | $24 |
| Nevro Corp. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $20 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $16 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- bio-ConneKt$199
- INTELLIS ADAPTIVESTIM$155
- Portfolio$149
- Qutenza$130
- PURAPLY WOUND MATRIX$126
How this compares
$2,293 in reported general payments places this provider in the 55th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 14 | $229 |
| Doxycycline Hyclate | 17 | $219 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $207 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $151 |
| Tramadol Hcl | 11 | $76 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Puyallup
- Mallory SchweitzerPuyallup$13K
- Jeffrey ChristensenEverett$884K
- David DalstromSeattle$497K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.